Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines -- 25+ years of biotherapeutics leadership, including serving as ...

For the first time, scientists have answered a longstanding question in cell biology about a partnership of proteins called ...

A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...

Seasoned biopharma industry leader brings more than 30 years of experience to support company’s growth trajectory —BERKELEY, Calif.--(BUSINESS WIRE)--Ray Therapeutics, a clinical-stage biotechnology ...

Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye-called the ...

A new meeting report was published in Volume 17, Issue 12 of Aging-US on December 23, 2025, titled "Cellular senescence meets ...

Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into ...

Increased use of organoids in cancer research: The Würzburg lighthouse project "Preclinical Models" is working towards this ...

RefleXion Medical, an external-beam theranostic oncology company, today announced the U.S. Food and Drug Administration has cleared its next generation, autonomously-guided oncology platform, the ...

Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced the expansion of its Scientific Advisory ...

If you're considering a vitamin B12 supplement because of certain dietary restrictions, medical conditions or your age, this ...

Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...